BMEA vs CTAS
Biomea Fusion Inc (BMEA) versus Cintas Corporation (CTAS) — a side-by-side from cached financials, not a winner call.
Biomea Fusion Inc (BMEA) is a biotechnology company listed on US.
Cintas Corporation (CTAS) is a specialty business services company listed on US.
BMEA does not have a complete income-statement cache yet.
Latest reported CTAS revenue for 2025-05-31 was $10.34B. Net income was $1.81B. Revenue was up 7.7% from 2024-05-31 to 2025-05-31. CTAS currently screens at market cap $89.01B and trailing P/E 51.3.
BMEA currently screens at market cap $94.7M. CTAS currently screens at market cap $89.01B and trailing P/E 51.3.
Not investment advice. Open the BMEA and CTAS stock pages for the full models.
Not investment advice.